Cryosurgical unit, general-purpose Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

cryosurgical unit, general-purpose

medtronic australasia pty ltd - 11067 - cryosurgical unit, general-purpose - a unit that stores and controls the delivery of liquid nitrous oxide under high pressure through the coaxial umbilical cable to the catheter, recovers the refrigerant vapor from the catheter under vacuum, and disposes the refrigerant through the hospital?s scavenging system. it can also record the cryotherapy procedure.

SUTENT 12.5 MG Israel - anglès - Ministry of Health

sutent 12.5 mg

pfizer pharmaceuticals israel ltd - sunitinib as malate - capsules - sunitinib as malate 12.5 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

SUTENT 25 MG Israel - anglès - Ministry of Health

sutent 25 mg

pfizer pharmaceuticals israel ltd - sunitinib as malate - capsules - sunitinib as malate 25 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

SUTENT 50 MG Israel - anglès - Ministry of Health

sutent 50 mg

pfizer pharmaceuticals israel ltd - sunitinib as malate - capsules - sunitinib as malate 50 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.

Sunitinib AqVida Capsules Hard 25mg Malta - anglès - Medicines Authority

sunitinib aqvida capsules hard 25mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib AqVida Capsules Hard 37.5mg Malta - anglès - Medicines Authority

sunitinib aqvida capsules hard 37.5mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib AqVida Capsules Hard 50mg Malta - anglès - Medicines Authority

sunitinib aqvida capsules hard 50mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Sunitinib AqVida Capsules Hard 12.5mg Malta - anglès - Medicines Authority

sunitinib aqvida capsules hard 12.5mg

aqvida gmbh kaiser-wilhelm-str 89, 20355 hamburg, germany - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Remedica 12.5mg Hard Capsules Malta - anglès - Medicines Authority

sunitinib remedica 12.5mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Remedica 25mg Hard Capsules Malta - anglès - Medicines Authority

sunitinib remedica 25mg hard capsules

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents